Safety Report: Endologix® Inc. Ovation iX Stent Graft System - zurückgerufen wegen Materialschwäche, United States
vor 4 Jahren •source fda.gov
Recall notice
United States
Company name: Endologix® Inc.Brand name: Ovation
Product recalled: Ovation iX system
Reason of the recall: A material weakness adjacent to the polymer fill channel may become compromised during pressurization with liquid polymer.
FDA Recall date: July 08, 2020
Recall details: Company Announcement Endologix® Inc. (Nasdaq: ELGX) (“Endologix” or the “Company”), a developer and marketer of innovative treatments for aortic disorders, today announced that a correction notice has been issued for the Ovation iX system, that identifies the root cause of polymer leaks. This voluntary action has been classified by the FDA as a Class 1 recall. No physical product removal of the product is planned or needed. Correction Z-2263-2020 was issued in May 2020 to current users of the Ovation iX system and informs users of a material weakness adjacent to the polymer fill channel that may become compromised during pressurization with liquid polymer. The clinical sequelae associated with polymer leaks may be systemic or aneurysm related. All lots/serial numbers, not yet implanted, of the following models are in the scope of the correction:
Check the full recall details on www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/endologix-issues-correction-notice-ovation-ix-abdominal-stent-graft-system
Source: FDA
Bemerkungen
Kommentar